Ardsley Advisory Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.7M | Sell |
400,000
-100,000
| -20% | -$1.68M | 0.88% | 37 |
|
|
2025
Q1 | $7.69M | Buy |
500,000
+200,000
| +67% | +$3.07M | 1.47% | 14 |
|
|
2024
Q4 | $6.61M | Sell |
300,000
-52,900
| -15% | -$1.17M | 1.05% | 26 |
|
|
2024
Q3 | $6.36M | Buy |
352,900
+102,150
| +41% | +$1.84M | 1.05% | 35 |
|
|
2024
Q2 | $4.07M | Buy |
+250,750
| New | +$4.07M | 0.6% | 49 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 159 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 145 |
|
|
2017
Q2 | – | Sell |
-15,000
| Closed | -$481K | – | 157 |
|
|
2017
Q1 | $481K | Buy |
+15,000
| New | +$481K | 0.07% | 82 |
|
|
2016
Q2 | – | Sell |
-5,000
| Closed | -$268K | – | 189 |
|
|
2016
Q1 | $268K | Sell |
5,000
-85,000
| -94% | -$4.56M | 0.04% | 98 |
|
|
2015
Q4 | $5.91M | Buy |
+90,000
| New | +$5.91M | 0.77% | 38 |
|